CY1118118T1 - Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια - Google Patents

Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια

Info

Publication number
CY1118118T1
CY1118118T1 CY20161100716T CY161100716T CY1118118T1 CY 1118118 T1 CY1118118 T1 CY 1118118T1 CY 20161100716 T CY20161100716 T CY 20161100716T CY 161100716 T CY161100716 T CY 161100716T CY 1118118 T1 CY1118118 T1 CY 1118118T1
Authority
CY
Cyprus
Prior art keywords
cannabidiol
hypothermia
neuroprotection
cooperative
treatments
Prior art date
Application number
CY20161100716T
Other languages
English (en)
Inventor
Jose Martinez-Orgado
Geoffrey Guy
Original Assignee
Gw Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gw Pharma Limited filed Critical Gw Pharma Limited
Publication of CY1118118T1 publication Critical patent/CY1118118T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με τον συνδυασμό του φυτό-κανναβινοειδούς cannabidiol με θεραπευτική υποθερμία για χρήση στην θεραπεία της νεύρο-προστασίας ή της άστρο-προστασίας.
CY20161100716T 2012-06-08 2016-07-21 Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια CY1118118T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1210142.4A GB2504263B (en) 2012-06-08 2012-06-08 Synergistic therapies for neuroprotection
PCT/GB2013/051519 WO2013182862A1 (en) 2012-06-08 2013-06-10 Synergistic therapies of cannabidiol with hypothermia for neuroprotection

Publications (1)

Publication Number Publication Date
CY1118118T1 true CY1118118T1 (el) 2017-06-28

Family

ID=46605623

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100716T CY1118118T1 (el) 2012-06-08 2016-07-21 Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια

Country Status (18)

Country Link
US (1) US10220005B2 (el)
EP (1) EP2858633B1 (el)
JP (1) JP6284525B2 (el)
BR (1) BR112014030406A8 (el)
CA (1) CA2874968C (el)
CY (1) CY1118118T1 (el)
DK (1) DK2858633T3 (el)
ES (1) ES2583830T3 (el)
GB (1) GB2504263B (el)
HR (1) HRP20160905T1 (el)
HU (1) HUE028822T2 (el)
MX (1) MX356052B (el)
PL (1) PL2858633T3 (el)
PT (1) PT2858633T (el)
RS (1) RS55029B1 (el)
SI (1) SI2858633T1 (el)
SM (1) SMT201600265B (el)
WO (1) WO2013182862A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
ES2965754T3 (es) 2015-12-16 2024-04-16 Neurophyxia B V 2-Iminobiotina para uso en el tratamiento de lesiones de células cerebrales
CN109475586A (zh) 2016-06-29 2019-03-15 康纳塞斯创新公司 脱羧的大麻树脂、其用途和制备其的方法
GB2597281A (en) * 2020-07-20 2022-01-26 Gw Res Ltd Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
WO2009071096A2 (en) * 2007-12-05 2009-06-11 Neurokey A/S Combination of medical and physical cooling treatment of ischemic effects

Also Published As

Publication number Publication date
EP2858633B1 (en) 2016-07-13
RS55029B1 (sr) 2016-11-30
GB2504263B (en) 2015-09-16
BR112014030406A8 (pt) 2021-06-22
HUE028822T2 (en) 2017-01-30
WO2013182862A1 (en) 2013-12-12
HRP20160905T1 (hr) 2016-09-23
CA2874968C (en) 2020-02-18
GB2504263A (en) 2014-01-29
BR112014030406A2 (pt) 2017-06-27
US20150148872A1 (en) 2015-05-28
SMT201600265B (it) 2016-08-31
US10220005B2 (en) 2019-03-05
JP6284525B2 (ja) 2018-02-28
DK2858633T3 (en) 2016-08-15
MX356052B (es) 2018-05-11
EP2858633A1 (en) 2015-04-15
US20160243054A2 (en) 2016-08-25
ES2583830T3 (es) 2016-09-22
SI2858633T1 (sl) 2016-10-28
PT2858633T (pt) 2016-07-29
PL2858633T3 (pl) 2016-11-30
JP2015518875A (ja) 2015-07-06
GB201210142D0 (en) 2012-07-25
CA2874968A1 (en) 2013-12-12
MX2014014839A (es) 2015-02-12
US20150328171A2 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
CY1124311T1 (el) Παρεμποδιστες dna-pk
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
BR112016014410A2 (pt) terapia de combinação com vacina de neoantígeno
GT201500190A (es) Lactamas fusionadas de arilo y heteroarilo
CL2014001993A1 (es) Uso de melatonina para el tratamiento de trastornos del ritmo circadiano
EA201790737A1 (ru) Комбинированная терапия
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
CY1119603T1 (el) Οιστρογονικα παραγωγα για χρηση στην αγωγη νευρολογικων διαταραχων
CO7180225A2 (es) Tratamientos de combinación para melanoma que comprenden la administración de cobimetinib y vemurafenib
EA201590343A1 (ru) Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний
EA201590703A1 (ru) Ингибиторы mek при лечении вирусных заболеваний
MX2013006392A (es) Tratamiento de cancer positivo para her2 con paclitaxel y trastuzumab-mcc-dm1.
BR112015029386A2 (pt) uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer
MX2015014046A (es) Combinaciones de farmacos para tratar cancer.
CY1117620T1 (el) Τριτοκαλινη για χρηση στην αντιμετωπιση της κυστικης ινωσης
EA201500371A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМБИНАЦИИ, СОДЕРЖАЩИЕ ДВОЙНЫЕ АНГИПОЭТИН-2/Dll4 СВЯЗЫВАЮЩИЕ АГЕНТЫ И АНТИ-VEGF АГЕНТЫ
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
CR20140400A (es) Terapia combinada para el tratamiento del cancer de ovario
CY1118118T1 (el) Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
EA201500370A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМБИНАЦИИ, СОДЕРЖАЩИЕ ДВОЙНЫЕ АНГИОПОЭТИН-2/Dll4 СВЯЗЫВАЮЩИЕ АГЕНТЫ И АНТИ-VEGF-R АГЕНТЫ
CY1119470T1 (el) Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη
UA117809C2 (uk) Похідні бендамустину, споріднені сполуки та їхнє медичне застосування для лікування раку